Chimera Investment Corporation
Chimera Investment Corporation (CIM-PD) Financial Performance & Income Statement Overview
Explore the financials of Chimera Investment Corporation (CIM-PD), including yearly and quarterly data on income, cash flow, and balance sheets.
Chimera Investment Corporation (CIM-PD) Income Statement & Financial Overview
View the income breakdown for Chimera Investment Corporation CIM-PD across both annual and quarterly reports.
| Metric | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|
| Revenue | $196.95M | -$113.51M | $151.96M | $73.67M |
| Cost of Revenue | $7.43M | $7.33M | $7.33M | $7.47M |
| Gross Profit | $189.28M | -$117.96M | $151.96M | $69.98M |
| Gross Profit Ratio | $0.96 | $1.04 | $1.00 | $0.95 |
| R&D Expenses | $0.00 | $0.00 | $0.00 | $0.00 |
| SG&A Expenses | $19.99M | $23.53M | $12.81M | $13.29M |
| Operating Expenses | $196.95M | -$113.51M | $151.96M | $73.67M |
| Total Costs & Expenses | $27.42M | -$113.51M | $151.96M | $73.67M |
| Interest Income | $190.62M | $192.36M | $195.29M | $186.72M |
| Interest Expense | $121.40M | $126.54M | $128.84M | $119.42M |
| Depreciation & Amortization | $951000.00 | $0.00 | $0.00 | $0.00 |
| EBITDA | $291.40M | $0.00 | $0.00 | $0.00 |
| EBITDA Ratio | $1.48 | $0.00 | $0.00 | $0.00 |
| Operating Income | $0.00 | -$19.98M | $0.00 | $0.00 |
| Operating Income Ratio | $0.00 | $0.18 | $0.00 | $0.00 |
| Other Income/Expenses (Net) | -$4.52M | -$5.03M | $136.47M | $56.70M |
| Income Before Tax | $169.05M | -$146.52M | $136.47M | $56.70M |
| Income Before Tax Ratio | $0.86 | $1.29 | $0.90 | $0.77 |
| Income Tax Expense | $1.75M | -$6000.00 | $16000.00 | $31000.00 |
| Net Income | $167.30M | -$146.51M | $136.46M | $56.66M |
| Net Income Ratio | $0.85 | $1.29 | $0.90 | $0.77 |
| EPS | $1.79 | -$1.81 | $1.41 | $0.42 |
| Diluted EPS | $1.77 | -$1.78 | $1.39 | $0.41 |
| Weighted Avg Shares Outstanding | $81.35M | $81.16M | $80.81M | $81.33M |
| Weighted Avg Shares Outstanding (Diluted) | $82.39M | $82.28M | $81.86M | $82.28M |
Over the past four quarters, Chimera Investment Corporation demonstrated steady revenue growth, increasing from $73.67M in Q2 2024 to $196.95M in Q1 2025. Operating income reached $0.00 in Q1 2025, maintaining a consistent N/A margin over recent quarters. Despite fluctuations in R&D and SG&A expenses, EBITDA remained robust at $291.40M, reflecting operational efficiency. Net income rose to $167.30M, with EPS at $1.79. Disciplined expense management helped sustain profitability, highlighting solid overall financial performance.
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan